Skip to content

Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage

Aquacel vs. Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage: A Randomized Control Study

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00984022
Enrollment
92
Registered
2009-09-24
Start date
2008-03-31
Completion date
2010-02-23
Last updated
2017-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abscess, Cellulitis

Keywords

abscess, MRSA, Aquacel dressing, Iodoform dressing

Brief summary

This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess.

Detailed description

The large increase in the incidence of skin and soft tissue infections cause by methicillin resistant staphylococcus aureus (MRSA) has produced a corresponding increase in the number of ED patients presenting with abscesses that require incision and drainage. This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess. More effective abscess healing will reduce the need for oral antibiotic coverage, which will in turn reduce the potential for drug resistance caused by indiscriminate use of oral antibiotics.

Interventions

DEVICEType of dressing - Iodoform

Dressing for packing a cutaneous abscess

DEVICEType of dressing - Aquacel

Aquacel dressing

Sponsors

Valleywise Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Aquacel vs. Iodoform Gauze

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* presenting to Maricopa Medical Center ED with cutaneous abscess requiring incision and drainage

Exclusion criteria

* known sensitivity to Aquacel * pregnant, nursing, or expecting to become pregnant * incarcerated patient * prior treatment of same abscess with incision and drainage * multiple abscesses * immunodeficiency * facial abscess * suspected osteomyelitis or septic arthritis * diabetic foot, decubitis, or ischaemic ulcers * unable to provide informed consent or assent

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Abscess2 weeksParticipants were assessed to see whether or not the surface area of the abscess was reduced by at least 30%, and the number of such participants is reported.

Secondary

MeasureTime frameDescription
Change in Patient Rating of PainBaseline and 2 weeksChange in mean pain score based on patient self-report, using Wong-Baker FACES pain rating scale. Scale ranges from 0 to 5, where 5 means the worst pain possible and 0 means no pain at all.
Number of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Cellulitis.2 weeksParticipants were assessed to see whether or not the surface area of the cellulitis was reduced by at least 30% and the number of such participants was reported.

Countries

United States

Participant flow

Participants by arm

ArmCount
Iodoform Dressing
Iodoform dressing for cutaneous abscess. Iodoform packing strips provided by Kendall, Curity, Tyco Healthcare Group LP, Mansfield, MA. Placed in the cavity after incision and drainage.
43
Aquacel Dressing
Aquacel dressing for cutaneous abscess. Aquacel Ag ribbons (Conva Tec Ltd., Skillman, NJ). Placed in the cavity after incision and drainage.
49
Total92

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up1014

Baseline characteristics

CharacteristicAquacel DressingIodoform DressingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
49 Participants43 Participants92 Participants
Age, Continuous39.2 years
STANDARD_DEVIATION 11.6
36.8 years
STANDARD_DEVIATION 12.6
38.0 years
STANDARD_DEVIATION 12
Region of Enrollment
United States
49 participants43 participants92 participants
Sex: Female, Male
Female
16 Participants15 Participants31 Participants
Sex: Female, Male
Male
33 Participants28 Participants61 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 430 / 49
serious
Total, serious adverse events
0 / 430 / 49

Outcome results

Primary

Number of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Abscess

Participants were assessed to see whether or not the surface area of the abscess was reduced by at least 30%, and the number of such participants is reported.

Time frame: 2 weeks

ArmMeasureValue (NUMBER)
Iodoform DressingNumber of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Abscess6 Participants
Aquacel DressingNumber of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Abscess19 Participants
Comparison: The percentages achieving 30% or greater reduction in the surface area of the abscess were compared with Fisher's exact test.p-value: 0.0003Fisher Exact
Secondary

Change in Patient Rating of Pain

Change in mean pain score based on patient self-report, using Wong-Baker FACES pain rating scale. Scale ranges from 0 to 5, where 5 means the worst pain possible and 0 means no pain at all.

Time frame: Baseline and 2 weeks

ArmMeasureValue (MEAN)Dispersion
Iodoform DressingChange in Patient Rating of Pain-1.23 Scores on a scaleStandard Deviation 1.89
Aquacel DressingChange in Patient Rating of Pain-1.82 Scores on a scaleStandard Deviation 1.73
Comparison: Repeated measures ANOVA using 2 X 2 factorial design, with one between-subjects factor (Group) and one within-subjects factor (Time). Null hypothesis is: The type of dressing does not affect patient pain ratings.p-value: 0.043ANOVA
Secondary

Number of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Cellulitis.

Participants were assessed to see whether or not the surface area of the cellulitis was reduced by at least 30% and the number of such participants was reported.

Time frame: 2 weeks

ArmMeasureValue (NUMBER)
Iodoform DressingNumber of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Cellulitis.13 Participants
Aquacel DressingNumber of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Cellulitis.13 Participants
Comparison: Fisher's exact test was used to compare the percentage of individuals achieving a 30% or greater reduction in cellulitis surface area between the Iodoform and Aquacel groups.p-value: 0.847Fisher Exact

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026